Loading clinical trials...
Loading clinical trials...
This study aims to compare 28-day mortality among patients with carbapenem resistant A. baumannii infections in two hypothetical target trials where patients receive 7 days of a cefiderocol-based trea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institutes of Health Clinical Center (CC)
NCT07029932 · Infectious Diseases, Antimicrobial Drug Resistance
NCT07118384 · Acinetobacter Baumannii Infection
NCT07004049 · Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, and more
NCT07177690 · Penicillin Allergy, Antimicrobial Drug Resistance, and more
NCT06167083 · Carbapenem Resistant Bacterial Infection
National Institutes of Health Clinical Center
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions